当前位置: X-MOL 学术BBA Mol. Cell Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ( IF 5.1 ) Pub Date : 2020-01-21 , DOI: 10.1016/j.bbamcr.2020.118659
Jintao Lin 1 , Tao Song 1 , Cong Li 1 , Weifeng Mao 1
Affiliation  

Glycogen synthase kinase-3β (GSK-3β) is an evolutionarily conserved serine/threonine kinase, functioning in numerous cellular processes including cell proliferation, DNA repair, cell cycle, signaling and metabolic pathways. GSK-3β is implicated in different diseases including inflammation, neurodegenerative disease, diabetes and cancers. GSK-3β is involved in biological processes of tumorigenesis, therefore, it is rational that GSK-3β inhibitors were employed to target malignant tumors. The effects of GSK-3β inhibitors in combination of radiation and chemotherapeutic drugs have been reported in various types of cancers, suggesting GSK-3β would play important roles in cancer treatments. GSK-3β is involved in multiple signal pathway including Wnt/β-catenin, PI3K/PTEN/AKT and Notch. GSK-3β also functions in DNA repair through phosphorylation of DNA repair factors and affecting their binding to chromatin. This review focuses on the molecular mechanism of GSK-3β in DNA repair, special in base excision repair and double-strands break repair, the roles of GSK-3β in inhibition of apoptosis through activation of NF-κB, and the effects of GSK-3β inhibitors on radio- and chemosensitization of various types of cancers. This article is part of a Special Issue entitled: GSK-3 and related kinases in cancer, neurological and other disorders edited by James McCubrey, Agnieszka Gizak and Dariusz Rakus.

中文翻译:

GSK-3β在DNA修复,细胞凋亡,化学疗法的抗性,癌症的放射治疗中。

糖原合酶激酶3β(GSK-3β)是一种进化保守的丝氨酸/苏氨酸激酶,在许多细胞过程中起作用,包括细胞增殖,DNA修复,细胞周期,信号传导和代谢途径。GSK-3β与多种疾病有关,包括炎症,神经退行性疾病,糖尿病和癌症。GSK-3β参与肿瘤发生的生物学过程,因此,采用GSK-3β抑制剂靶向恶性肿瘤是合理的。已经报道了GSK-3β抑制剂与放射线和化学治疗药物联合在多种类型的癌症中的作用,表明GSK-3β在癌症治疗中将发挥重要作用。GSK-3β参与多个信号途径,包括Wnt /β-catenin,PI3K / PTEN / AKT和Notch。GSK-3β还通过DNA修复因子的磷酸化并影响其与染色质的结合而在DNA修复中起作用。本文综述了GSK-3β在DNA修复中的分子机制,特别是碱基切除修复和双链断裂修复,GSK-3β在通过激活NF-κB抑制细胞凋亡中的作用,以及GSK- 3β抑制剂对各种类型的癌症的放射敏感性和化学敏感性。本文是特刊的一部分,该刊物由James McCubrey,Agnieszka Gizak和Dariusz Rakus编辑,题为:癌症,神经系统疾病和其他疾病中的GSK-3和相关激酶。GSK-3β通过激活NF-κB抑制细胞凋亡的作用,以及GSK-3β抑制剂对各种类型的癌症的放射敏感性和化学敏感性的影响。本文是特刊的一部分,该刊物由James McCubrey,Agnieszka Gizak和Dariusz Rakus编辑,题为:癌症,神经系统疾病和其他疾病中的GSK-3和相关激酶。GSK-3β通过激活NF-κB抑制细胞凋亡的作用,以及GSK-3β抑制剂对各种类型的癌症的放射敏感性和化学敏感性的影响。本文是特刊的一部分,该刊物由James McCubrey,Agnieszka Gizak和Dariusz Rakus编辑,题为:癌症,神经系统疾病和其他疾病中的GSK-3和相关激酶。
更新日期:2020-01-22
down
wechat
bug